Nicolas Danchin

Summary

Country: France

Publications

  1. ncbi Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, Paris, France
    Am Heart J 150:1147-53. 2005
  2. ncbi A view from Paris: Nicolas Danchin, MD, FESC. Interview by Robert Short
    Nicolas Danchin
    Circulation 115:f97-9. 2007
  3. ncbi Impact of free universal medical coverage on medical care and outcomes in low-income patients hospitalized for acute myocardial infarction: an analysis from the FrenchNational Health Insurance system
    Nicolas Danchin
    Department of Coronary Artery Disease, Hopital Europeen Georges Pompidou, Assistance Publique Hôpitaux de Paris and Université René Descartes 5, 20 rue Leblanc, Paris, France
    Circ Cardiovasc Qual Outcomes 4:619-25. 2011
  4. ncbi Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis
    Nicolas Danchin
    Department of Coronary Artery Disease and Acute Cardiac Care, Hopital Europeen Georges Pompidou, Paris, France
    Cardiology 120:59-72. 2011
  5. ncbi [Optimizing long-term therapy: dawn of a new era]
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
    Am J Cardiovasc Drugs 7:13-6. 2007
  6. ncbi [Cardiovascular risk factors: on which elements to base the actions of prevention?]
    Nicolas Danchin
    Service de Cardiologie médicale, unité 3, HEGP, 75908 Paris
    Rev Prat 55:1753-4. 2005
  7. ncbi [Epidemiology of acute coronary syndromes in France and in Europe]
    N Danchin
    Hopital Europeen Georges Pompidou, Pôle Cardiovasculaire, 20 rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 59:S37-41. 2010
  8. ncbi [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]
    N Danchin
    Departement de Cardiologie, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Ann Cardiol Angeiol (Paris) 56:82-7. 2007
  9. ncbi Systems of care for ST-segment elevation myocardial infarction: impact of different models on clinical outcomes
    Nicolas Danchin
    Department of Cardiology, European Hospital Georges Pompidou of Paris, Paris, France
    JACC Cardiovasc Interv 2:901-8. 2009
  10. ncbi Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial
    Nicolas Danchin
    Service de cardiologie, Hopital Europeen Georges Pompidou, Assistance Publique des Hopitaux de Paris, Universite Paris Descartes, Paris, France
    Therapie 64:111-4. 2009

Detail Information

Publications115 found, 100 shown here

  1. ncbi Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, Paris, France
    Am Heart J 150:1147-53. 2005
    ..Several classes of medications improve survival in patients with coronary artery disease. Whether these medications, as used in the real world, have additive efficacy remains speculative...
  2. ncbi A view from Paris: Nicolas Danchin, MD, FESC. Interview by Robert Short
    Nicolas Danchin
    Circulation 115:f97-9. 2007
  3. ncbi Impact of free universal medical coverage on medical care and outcomes in low-income patients hospitalized for acute myocardial infarction: an analysis from the FrenchNational Health Insurance system
    Nicolas Danchin
    Department of Coronary Artery Disease, Hopital Europeen Georges Pompidou, Assistance Publique Hôpitaux de Paris and Université René Descartes 5, 20 rue Leblanc, Paris, France
    Circ Cardiovasc Qual Outcomes 4:619-25. 2011
    ..The type of medical coverage in patients with acute myocardial infarction (AMI) may affect their treatment and outcome...
  4. ncbi Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis
    Nicolas Danchin
    Department of Coronary Artery Disease and Acute Cardiac Care, Hopital Europeen Georges Pompidou, Paris, France
    Cardiology 120:59-72. 2011
    ..To compare the antianginal efficacy of trimetazidine with that of other agents with no influence on heart rate...
  5. ncbi [Optimizing long-term therapy: dawn of a new era]
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
    Am J Cardiovasc Drugs 7:13-6. 2007
    ..g. statin-acetylsalicylic acid, thus makes it possible to reduce the number of tablets to be taken at any one time, thus potentially increasing treatment compliance and the efficacy of the treatment administered...
  6. ncbi [Cardiovascular risk factors: on which elements to base the actions of prevention?]
    Nicolas Danchin
    Service de Cardiologie médicale, unité 3, HEGP, 75908 Paris
    Rev Prat 55:1753-4. 2005
  7. ncbi [Epidemiology of acute coronary syndromes in France and in Europe]
    N Danchin
    Hopital Europeen Georges Pompidou, Pôle Cardiovasculaire, 20 rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 59:S37-41. 2010
    ..Acute coronary syndromes, however, remain severe clinical conditions, which carry a high mid-term and long-term morbi-mortality and deserve further efforts to develop new therapeutic tools...
  8. ncbi [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]
    N Danchin
    Departement de Cardiologie, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Ann Cardiol Angeiol (Paris) 56:82-7. 2007
    ..00 g/l compared to atorvastatin at the same dose. However, many patients remain not at goal...
  9. ncbi Systems of care for ST-segment elevation myocardial infarction: impact of different models on clinical outcomes
    Nicolas Danchin
    Department of Cardiology, European Hospital Georges Pompidou of Paris, Paris, France
    JACC Cardiovasc Interv 2:901-8. 2009
    ....
  10. ncbi Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial
    Nicolas Danchin
    Service de cardiologie, Hopital Europeen Georges Pompidou, Assistance Publique des Hopitaux de Paris, Universite Paris Descartes, Paris, France
    Therapie 64:111-4. 2009
    ....
  11. ncbi Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, Paris, Université de Paris René Descartes, Paris, France
    Cardiovasc Drugs Ther 24:325-30. 2010
    ..The combination of antiplatelet and anticoagulant agents should be chosen according to the patients' characteristics and the management strategy of the acute coronary syndrome...
  12. ncbi [Weight change, cardiometabolic risk and the impact of antidiabetic medications in type 2 diabetic patients]
    N Danchin
    Division maladies coronaires et soins intensifs, faculté Paris Descartes, Hopital Europeen Georges Pompidou, AP HP, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 59:214-20. 2010
    ..The second part of the review focuses on the impact of antidiabetic medications on weight, emphasising the importance of a comprehensive approach, taking into account weight, in the management of diabetic patients...
  13. ncbi Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register
    Nicolas Danchin
    Cardiology Department, Hoˆpital Europe en Georges Pompidou and Universite Paris Descartes, Paris, France
    Heart 96:1809-14. 2010
    ..The aim of this study was to determine correlations between early statin therapy and atrial fibrillation in acute myocardial infarction...
  14. ncbi Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey
    Nicolas Danchin
    Cardiology Department, Hopital Europeen Georges Pompidou, Paris, France
    Int J Cardiol 133:32-40. 2009
    ..We evaluated correlates of prolonged use of evidence-based therapies in patients discharged after non-ST-segment elevation acute coronary syndrome (NSTE ACS)...
  15. ncbi Use of drug eluting stents: expert consensus of the French Society of Cardiology
    N Danchin
    Service de cardiologie, , 20 rue Leblanc, Paris Cedex 15
    Arch Cardiovasc Dis 101:190-3. 2008
  16. ncbi [Risk stratification of acute coronary syndromes]
    N Danchin
    Hopital Europeen Georges Pompidou, Paris Cedex 15, France
    Ann Cardiol Angeiol (Paris) 56:S16-20. 2007
    ..These variables can be used to construct risk scores, among which the TIMI and GRACE scores are the most widely used. These scores may prove helpful to define the optimal diagnostic and therapeutic management of the patients...
  17. ncbi Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial inf
    Nicolas Danchin
    Division of Coronary Artery Disease and Intensive Cardiac Care, Hopital Europeen Georges Pompidou, Assistance Publique des Hôpitaux de Paris and Faculté René Descartes, Universite Paris 5, 20 rue Leblanc, 75015 Paris, France
    Circulation 118:268-76. 2008
    ....
  18. ncbi Pre-hospital thrombolysis in perspective
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, Assistance Publique des Hôpitaux de Paris and Université Paris 5 René Descartes, Paris, France
    Eur Heart J 29:2835-42. 2008
    ..To review existing evidence on the role of pre-hospital fibrinolysis in patients with ST-elevation myocardial infarction (MI)...
  19. ncbi Central pulse pressure and atherosclerotic alterations of coronary arteries
    Nicolas Danchin
    Department of Cardiology, Hopital Europeen Georges Pompidou, Paris, France
    Adv Cardiol 44:139-49. 2007
    ..Finally, the ASCOT-CAFE trial found a positive correlation between pulse pressure and the occurrence of cardiovascular events, confirming the prognostic significance of this parameter...
  20. ncbi Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry
    Nicolas Danchin
    Service de cardiologie, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
    Circulation 110:1909-15. 2004
    ..Limited data are available on the impact of prehospital thrombolysis (PHT) in the "real-world" setting...
  21. ncbi Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry
    Etienne Puymirat
    Division of Coronary Artery Disease and Intensive Cardiac Care, Georges Pompidou European Hospital, Assistance Publique Hopitaux de Paris AP HP, Paris Descartes University, 20, rue Leblanc, 75015 Paris, France
    Arch Cardiovasc Dis 105:347-54. 2012
    ..Recent clinical studies suggest that low-molecular-weight heparin (LMWH) could be an effective and safe alternative to unfractionated heparin (UFH) for patients with acute myocardial infarction (AMI)...
  22. ncbi Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database
    Philippe Tuppin
    Département des études sur les pathologies et les patients, direction de la stratégie des études et des statistiques, Caisse nationale d assurance maladie des travailleurs salariés, Paris, France
    Arch Cardiovasc Dis 102:279-92. 2009
    ....
  23. ncbi French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010
    Michel Hanssen
    Department of Cardiology, centre hospitalier de Haguenau, Haguenau Cedex, France
    Heart 98:699-705. 2012
    ..Linkage with Institute for National Statistics. ACCESS TO DATA: Available for research to any participating clinician upon request to executive committee (fastmi2010@yahoo.fr)...
  24. ncbi Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome)
    Etienne Puymirat
    Division of Coronary Artery Disease and Intensive Cardiac Care, European Hospital of Georges Pompidou, Assistance Publique des Hopitaux de Paris AP HP, University Paris Descartes, Paris, France
    JACC Cardiovasc Interv 5:893-902. 2012
    ....
  25. ncbi Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction
    Etienne Puymirat
    Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Department of Cardiology, Universite Paris Descartes, and INSERM U 970, Paris, France
    JAMA 308:998-1006. 2012
    ..The contemporary decline in mortality reported in patients with ST-segment elevation myocardial infarction (STEMI) has been attributed mainly to improved use of reperfusion therapy...
  26. ncbi Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project
    Anouk Meizels
    INSERM U 698 Recherche Clinique en Athérothrombose, Service de cardiologie, Centre Hospitalier Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, université Paris VII Denis Diderot, 75877 Paris Cedex 18, France
    Arch Cardiovasc Dis 103:207-14. 2010
    ..A substantial number of patients with acute myocardial infarction (AMI) have polyvascular disease (PolyVD), defined as cerebrovascular disease (CVD), peripheral arterial disease (PAD) or both...
  27. ncbi Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry
    Nicolas Danchin
    Service de cardiologie, HEGP, Paris, France
    Diabetes Metab Res Rev 21:143-9. 2005
    ..The cardiovascular effects of sulfonylureas (SU) in diabetic patients are controversial and it has been suggested that diabetic patients with acute myocardial infarction while on SU were at increased risk...
  28. ncbi Comparison of efficacy and safety of a standard versus a loading dose of clopidogrel for acute myocardial infarction in patients ≥ 75 years of age (from the FAST-MI registry)
    Etienne Puymirat
    Division of Coronary Artery Disease and Intensive Cardiac Care, Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France
    Am J Cardiol 108:755-9. 2011
    ..Large-scale randomized trials are still needed to identify the optimal LD of clopidogrel for elderly patients admitted for AMI...
  29. ncbi Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the French nation-wide USIC registries
    Tabassome Simon
    Department of Pharmacology, Saint Antoine, Pierre et Marie Curie University, 27 rue Chaligny, 75012 AP HP, and Department of Cardiology, Hopital Europeen Georges Pompidou, Paris, France
    Eur Heart J 27:1282-8. 2006
    ..To determine whether sex differences of in-hospital and after-discharge mortality differ according to the age...
  30. ncbi Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI)
    Jean Ferrieres
    Cardiology Department, CHU Rangueil, Toulouse, France
    Atherosclerosis 204:491-6. 2009
    ....
  31. ncbi Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries
    Nadia Aissaoui
    Division of Coronary Artery Disease and Intensive Cardiac Care, Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France
    Eur Heart J 33:2535-43. 2012
    ..The historical evolution of incidence and outcome of cardiogenic shock (CS) in acute myocardial infarction (AMI) patients is debated. This study compared outcomes in AMI patients from 1995 to 2005, according to the presence of CS...
  32. ncbi Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry
    Yves Juilliere
    Departement de Cardiologie, Centre Hospitalier Universitaire, Nancy Brabois Vandoeuvre les Nancy, France
    Rev Esp Cardiol (Engl) 65:326-33. 2012
    ..To compare acute myocardial infarction patients with or without congestive heart failure in the French FAST-MI registry...
  33. ncbi Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome
    Yves Cottin
    Department of Cardiology, Centre Hopsitalier Universitaire de Dijon, France
    J Cardiopulm Rehabil 24:38-44. 2004
    ..These findings may help to modify the strategy for using cardiac rehabilitation after acute coronary syndrome, although it is an effective intervention for secondary prevention...
  34. ncbi Performance assessment of a chest pain unit: Preliminary 2-year experience in the European Georges Pompidou Hospital
    Eric Durand
    Service de cardiologie, Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Arch Cardiovasc Dis 102:803-9. 2009
    ..Chest pain units (CPUs) are very popular in the USA for the triage of low-to-intermediate-risk chest pains. However, CPUs do not yet exist in France...
  35. ncbi Quality of care for myocardial infarction at academic and nonacademic hospitals
    Loic Belle
    Department of Cardiology, Annecy General Hospital, France
    Am J Med 125:365-73. 2012
    ..The aim of this study was to compare processes of care and mortality between academic and nonacademic hospitals in the contemporary era of acute myocardial infarction management...
  36. ncbi [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice]
    Francois Philippe
    Institut Mutualiste Montsouris, Département de Pathologie Cardiaque, Paris, France
    Ann Cardiol Angeiol (Paris) 54:S30-6. 2005
    ..Increasing observance which is the main challenge could involved the utilization of fixed drugs associations...
  37. ncbi Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009)
    Philippe Tuppin
    Caisse nationale d assurance maladie des travailleurs salariés, Paris, France
    Arch Cardiovasc Dis 104:332-42. 2011
    ..An ageing population and the extension of indications will in all probability result in an increasing number of cardiac device implantations...
  38. ncbi [Clinical aspects of acute coronary syndromes]
    Christophe Bensouda
    , , 20, rue Leblanc, 75015 Paris, France
    Med Sci (Paris) 20:402-7. 2004
    ..In all instances, secondary prevention measures are determinant to try and stop the progression of the atherosclerotic disease...
  39. ncbi Consensus of the French Society of Gerontology and Geriatrics and the French Society of Cardiology for the management of coronary artery disease in older adults
    Olivier Hanon
    Department of Geriatrics, Universite Paris Descartes, Hopital Broca, 54 56, rue Pascal, 75013 Paris, France
    Arch Cardiovasc Dis 102:829-45. 2009
    ....
  40. ncbi Occupational status moderates the association between current perceived stress and high blood pressure: evidence from the IPC cohort study
    Emmanuel Wiernik
    Unité de Psychologie et Psychiatrie de liaison et d urgence, Hopital Europeen Georges Pompidou, Paris, France
    Hypertension 61:571-7. 2013
    ..The association between current perceived stress and BP depends on occupational status. This interaction may account for previous conflicting results and warrants further studies to explore its underlying mechanisms...
  41. ncbi Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocard
    Tabassome Simon
    Department of Pharmacology, Clinical Research Unit, APHP, St Antoine Hospital, UMPC Paris 06 University, 27 rue Chaligny, Paris, France
    Circulation 123:474-82. 2011
    ..This analysis compares treatment outcomes for patients in the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) who did or did not receive clopidogrel and/or PPIs...
  42. ncbi [Combination therapy at hospital discharge in the USIC 2000 survey]
    Aures Chaib
    Hopital Europeen Georges Pompidou, Paris, France
    Ann Cardiol Angeiol (Paris) 54:S24-9. 2005
    ..Conclusions: compared with the prescription of any single class of secondary prevention medications, combination therapy offers additional protection in patients with acute myocardial infarction...
  43. ncbi Heart rate and completed suicide: evidence from the IPC cohort study
    Cédric Lemogne
    Universite Paris Descartes, Sorbonne Paris Cité, Faculté deMédecine, Paris, France
    Psychosom Med 73:731-6. 2011
    ..Moreover, the neural bases of HR and BP regulation are similar to those of emotion regulation. The present study examined whether high resting HR or BP would be associated with an increased risk of suicide...
  44. ncbi Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs
    Lamiae Grimaldi-Bensouda
    Equipe d acceuil Pharmacoépidémiologie et Maladies Infectieuses, Institut Pasteur, Paris, France
    Heart 97:1834-40. 2011
    ..The objective of this study was to explore the association of non-steroidal anti-inflammatory drugs (NSAID) with ST-segment elevation myocardial infarction (STEMI) and non-ST segment elevation myocardial infarction (NSTEMI)...
  45. ncbi Aortic pulse pressure is related to the presence and extent of coronary artery disease in men undergoing diagnostic coronary angiography: a multicenter study
    Nicolas Danchin
    Department of Cardiology, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
    Am J Hypertens 17:129-33. 2004
    ..In the general population, pulse pressure (PP) is a correlate of cardiovascular outcomes. Few data are available regarding the links between PP and documented coronary artery disease (CAD)...
  46. ncbi Clinical perspectives of heart rate slowing for coronary event reduction and heart failure
    Nicolas Danchin
    Department of Cardiology, Hopital Europeen Georges Pompidou, Paris, France
    Adv Cardiol 43:45-53. 2006
    ....
  47. ncbi [Choosing the right medication for the right patient]
    Eric Durand
    , , 75908 Paris
    Rev Prat 55:1805-11. 2005
    ..These medications should therefore constitute first line therapy. Beside the use of medications, life style changes (Mediterranean diet, physical exercise, smoking cessation) are also necessary...
  48. ncbi PCI at non-PCI centres: immediate or rescue?
    Nicolas Danchin
    Department of Coronary Artery Disease and Intensive Care, Hôpital Européen Georges Pompidou Assistance Publique des Hôpitaux de Paris, Universite Rene Descartes, 75015 Paris, France
    Lancet 371:534-6. 2008
  49. ncbi Stent-related cardiac events beyond three years after implantation of the sirolimus-eluting stent (from the EVASTENT Patients)
    Gilles Barone-Rochette
    Cardiology Department, Grenoble University Hospital, France
    Am J Cardiol 108:1401-7. 2011
    ..In conclusion, all-cause deaths continued at a steady rate over 6 years. However, cardiac deaths and "very" VLST leveled out beyond 3 years...
  50. ncbi Why socially deprived populations have a faster resting heart rate: impact of behaviour, life course anthropometry, and biology--the RECORD Cohort Study
    Basile Chaix
    INSERM U707, Paris, France
    Soc Sci Med 73:1543-50. 2011
    ..Future research should further clarify the mechanisms through which socioeconomic disadvantage influences resting heart rate, as a pathway to social disparities in cardiovascular morbidity/mortality...
  51. ncbi Heart rate reduction: a potential target for the treatment of myocardial ischaemia
    Nicolas Danchin
    Hopital Europeen Georges Pompidou, Paris, France
    Therapie 59:511-5. 2004
    ..However, only future studies will determine whether isolated heart rate reduction will have the same protective efficacy as that of beta-blocking agents in secondary prevention after myocardial infarction...
  52. ncbi Effect of reperfusion therapy on long-term outcome in patients >70 years of age
    Nicolas Danchin
    , , 20 rue Leblanc, 75015 Paris, France
    Am J Cardiol 90:1142-5. 2002
  53. ncbi Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials
    Nicolas Danchin
    Department of Cardiology, Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Paris, France
    Arch Intern Med 166:787-96. 2006
    ....
  54. ncbi [Gp IIb/IIIa receptor antagonists in acute coronary syndromes with no ST elevation]
    V Decalf
    Faculte de Medecine, Hopital Europeen Georges Pompidou, Service de cardiologie, Universite Paris Descartes
    Arch Mal Coeur Vaiss 100:1006-12. 2007
    ..Bivalirudin seems to compare well with Gp IIb/IIIa blockers in terms of ischemia, but it significantly reduces the occurrence of hemorrhagic events...
  55. ncbi Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults
    Matthieu Plichart
    INSERM, U970 Paris, France
    Eur J Prev Cardiol 20:61-72. 2013
    ..We thus aimed to examine the secular trends in HR and interrelationships between HR and traditional CV risk factors and mortality...
  56. ncbi Cause-specific mortality in diabetes: recent changes in trend mortality
    Charbel Abi Khalil
    Diabetology, Endocrinology and Nutrition Department, Hopital Bichat Claude Bernard, Paris, France
    Eur J Prev Cardiol 19:374-81. 2012
    ..This counteracts the diminution of diabetes-related mortality that would move forward on an ascending slope in the next decades...
  57. ncbi Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina
    Nicolas Danchin
    Division of Cardiology and Coronary Artery Disease, Hopital Europeen Georges Pompidou, Paris, France
    Am J Cardiol 98:8J-13J. 2006
    ....
  58. ncbi The new American Heart Association guidelines on the prevention of infective endocarditis: culmination of a long process of thought
    Xavier Duval
    , Denis Diderot, Paris, France
    Heart 94:715-6. 2008
  59. ncbi Genetic determinants of response to clopidogrel and cardiovascular events
    Tabassome Simon
    Assistance Publique Hopitaux de Paris, Hopital Saint Antoine, and Universite Pierre et Marie Curie, Paris 06, France
    N Engl J Med 360:363-75. 2009
    ..The effect of these determinants on clinical outcomes after an acute myocardial infarction is unknown...
  60. ncbi [Clinical and economical evaluation of bivalirudin during percutaneous coronary interventions]
    T Caruba
    Services de pharmacie, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 59:72-8. 2010
    ..0001). Bivalirudin can be an interesting alternative for patients with a high risk of having complications. But considering its cost this therapy must be used only for selected patients...
  61. ncbi [Case report and review of a voluminous right atrial myxoma revealed by heart failure]
    A Lepillier
    Service de cardiologie, Hopital Europeen Georges Pompidou, 20 rue Leblanc, Paris, France
    Ann Cardiol Angeiol (Paris) 59:37-9. 2010
    ..Its surgical excision under extracorporeal circulation was successfully performed. Histology confirmed the final diagnosis of myxoma. No complication was observed at 6 months follow-up...
  62. ncbi Acute myocardial infarction
    Nicolas Danchin
    , Paris, France
    Am Fam Physician 68:519-21. 2003
  63. ncbi Ischemic heart disease in type 2 diabetes
    Irina Otel
    Department of Cardiology, , Paris, France
    Metabolism 52:6-12. 2003
    ....
  64. ncbi [Prehospital management of very elderly patients with ST segment elevation in Paris by mobile intensive care units (Samu)]
    J E Leroy
    SAMU de Paris, , Paris, France
    Ann Cardiol Angeiol (Paris) 54:49-54. 2005
    ..Overall, the prehospital management of very elderly patients with suspected ST elevation infarction appears far from optimal...
  65. ncbi [Influence of percutaneous coronary intervention in non ST-elevation acute coronary syndromes on prescription of secondary prevention medications. Data from the S-Témoin Registry]
    N Danchin
    Service de cardiologie, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 56:30-5. 2007
    ..The interaction between the use of percutaneous coronary intervention (PCI) for non-ST-elevation acute coronary syndromes and the use of secondary prevention medications was analysed in the French S-Témoin Registry...
  66. ncbi N-terminal pro-brain natriuretic peptide levels in patients with non-ST-elevation myocardial infarction
    M Zeller
    Service de cardiologie, CHU Bocage, Dijon, France
    Cardiology 102:37-40. 2004
    ..105 pmol/l, p = 0.02). CONCLUSION: Our data in an unselected population of NSTEMI patients indicate that high levels of circulating Nt-proBNP levels are associated with an increased risk of early cardiovascular events...
  67. ncbi Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey
    A Oudot
    Service de cardiologie, CHU Bocage, Dijon, France
    Heart 92:1077-83. 2006
    ..Thus, further studies are warranted to develop specific management strategies for this high risk group...
  68. ncbi Long-term outcome in patients treated by intracoronary stenting with ticlopidine and aspirin, and deleterious prognostic role of unstable angina pectoris
    M Angioi
    Service de cardiologie, Hopitaux de Brabois, Vandoeuvre les Nancy, France
    Am J Cardiol 85:1065-70. 2000
    ..Thus, unstable angina at rest remains an adverse prognostic indicator in patients treated with intracoronary stents, particularly with regard to subsequent requirement of revascularization procedures and event-free survival...
  69. ncbi Prophylaxis of infective endocarditis: French recommendations 2002
    N Danchin
    Department of Cardiology, , 20 rue Leblanc, 75015 Paris, France
    Heart 91:715-8. 2005
  70. ncbi [Baseline characteristics and management of patients less than 45 years of age hospitalized for acute coronary syndromes: results from the nationwide French PREVENIR 1 and PREVENIR 2 studies]
    O Grenier
    Departement de Cardiologie, HEGP, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 51:15-9. 2002
    ..Left ventricular ejection fraction was less altered in the younger age group and none of the younger patients died between hospital discharge and six months follow-up...
  71. ncbi [Trends in discharge prescriptions for patients hospitalized for acute coronary syndromes in France from 1995 to 2000. Data from the Usik 1995, Prevenir 1, Prevenir 2 and Usic 2000 surveys]
    N Danchin
    Departement de Cardiologie, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 52:1-6. 2003
    ..The results of the recent trials of secondary prevention medications have had a considerable impact on real-life practice in France during the late 1990s...
  72. ncbi [Sirolimus endoprosthesis: data from the RAVEL and the SIRIUS study]
    D Blanchard
    , Paris, France
    Ann Cardiol Angeiol (Paris) 53:9s-12s. 2004
  73. ncbi [Unstable angina and acute myocardial infarction: main recent trials]
    N Danchin
    HEGP, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 51:44--7. 2002
  74. ncbi [What do registries bring us? The example of acute coronary syndromes]
    N Danchin
    Hopital Europeen Georges Pompidou, Cardiologie, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 52:159-61. 2003
    ..Both approaches are complementary and should be used to define the optimal management of patients. Lessons derived from registry data in acute coronary syndromes in the recent past in France are presented...
  75. ncbi [Glycoprotein IIb/IIIa inhibitors in unstable angina]
    K Boughalem
    Service de cardiologie, , Clinique Labrouste, Paris, France
    Ann Cardiol Angeiol (Paris) 50:377-84. 2001
    ..Results of large trials using this drugs suggest that this agents are effective in patient with unstable angina particularly in those presenting a high score of risk for acute ischemic events and those requiring coronary intervention...
  76. ncbi Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey
    N Danchin
    Department of Cardiology, University Hospital of Nancy Brabois, Vandoeuvre les Nancy, France
    Circulation 99:2639-44. 1999
    ..The aim of this study was to document 1-year outcome in patients receiving either thrombolysis or primary angioplasty for acute myocardial infarction in the "real world."..
  77. ncbi Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathy
    R M Rodriguez
    Service de cardiologie, CHU de Nancy Brabois, Vandoeuvre, France
    Am J Cardiol 88:185-8, A6. 2001
    ....
  78. ncbi [Management of patients admitted for acute myocardial infarction in France from 1995 to 2000: time to admission dependent improvement in outcome]
    N Danchin
    Cardiologie, Hopital Europeen Georges Pompidou, Leblanc, Paris
    Arch Mal Coeur Vaiss 98:1149-54. 2005
    ..This goes along with a shift in reperfusion therapy towards a broader use of primary angioplasty, and with an increased use of the early prescription of recognised secondary prevention medications...
  79. ncbi [Management of infarction with ST elevation in the acute phase: the current guidelines]
    N Danchin
    Service de cardiologie, Hopital Europeen Georges Pompidou, Leblanc, Paris
    Arch Mal Coeur Vaiss 98:1071-4. 2005
    ..Primary angioplasty should, whenever possible, constitute the default strategy, but intravenous thrombolysis still has an important role, particularly in the first few hours following symptom onset...
  80. ncbi Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study
    Z Kadri
    , Paris, France
    Heart 92:910-5. 2006
    ..CONCLUSION: In non-diabetic patients, raised admission blood glucose is a strong and independent predictor of both in-hospital and long term mortality...
  81. ncbi [The Cypher stent: most recent news of the 2004 Congress of the American College of Cardiology]
    C Bensouda
    , 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 53:40s-41s. 2004
  82. ncbi [The national registry EVASTENT: cost-effectiveness analysis of the sirolimus active stent in diabetic and non-diabetic patients]
    J Machecourt
    Service de cardiologie, CHU de Grenoble, France
    Ann Cardiol Angeiol (Paris) 53:22s-28s. 2004
  83. ncbi [Evolution of the management and outcomes of patients admitted for acute myocardial infarction in France from 1995 to 2000: data from the USIK 1995 and USIC 2000 nationwide registries]
    J P Cambou
    Service de cardiologie, , 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 53:12-7. 2004
    ..This goes along with a shift in reperfusion therapy towards a broader use of coronary angioplasty and with an increased use of the early prescription of recognised secondary prevention medications...
  84. ncbi Acute coronary syndromes: should women receive less antithrombotic medication than men?
    N Danchin
    Cardiologie, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
    Heart 90:363-6. 2004
    ....
  85. ncbi Management and short-term outcome of diabetic patients hospitalized for acute myocardial infarction: results of a nationwide French survey
    L Vaur
    Medical Department, Aventis, Paris, France
    Diabetes Metab 29:241-9. 2003
    ..To compare management and short-term outcome of diabetic and non-diabetic patients hospitalized for acute myocardial infarction...
  86. ncbi [Pulse pressure and coronary disease]
    N Danchin
    Service de cardiologie, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris
    Arch Mal Coeur Vaiss 95:7-10. 2002
    ..In addition, two small-sized studies have shown a strong correlation between pulse pressure and restenosis after conventional percutaneous transluminal coronary angioplasty...
  87. ncbi [Role of cardiologists in control of risk factors and prescription of secondary-preventive drugs in elderly patients with atherosclerotic cardiovascular disease. The French ELIAGE-MG survey]
    N Danchin
    Clinique des maladies coronaires, HEGP, 20, rue Leblanc, 75015 Paris, France
    Ann Cardiol Angeiol (Paris) 55:17-21. 2006
    ....
  88. ncbi Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry
    P G Steg
    Department of Cardiology, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Heart 92:1378-83. 2006
    ..To study the impact on outcomes of direct admission versus emergency room (ER) admission in patients with ST-segment elevation myocardial infarction (STEMI) DESIGN: Nationwide observational registry of STEMI patients..
  89. ncbi [Therapeutic management of heart failure and left ventricular dysfunction following acute myocardial infarction in French intensive care units]
    J P Cambou
    Société française de cardiologie, Paris, France
    Ann Cardiol Angeiol (Paris) 56:36-41. 2007
    ..To evaluate the therapeutic management of cardiac failure after myocardial infarction (MI) in French intensive cardiac care units (USIC) in 2005...
  90. ncbi The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004
    Lori Mandelzweig
    Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Israel
    Eur Heart J 27:2285-93. 2006
    ..CONCLUSION: Data from EHS-ACS-II suggest an increase in adherence to guidelines for treatment of ACS in comparison with EHS-ACS-I...
  91. ncbi Resting heart rate in cardiovascular disease
    Kim Fox
    Royal Brompton Hospital, Sydney Street, London SW3 6NP, England
    J Am Coll Cardiol 50:823-30. 2007
    ..These findings suggest that the potential role of HR and its modulation should be considered in future cardiovascular guidance documents...
  92. ncbi Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry)
    Jean Ferrieres
    Department of Epidemiology, INSERM U558, Toulouse, France
    Am J Cardiol 95:486-9. 2005
    ..57, 95% confidence interval 0.38 to 0.86, p <0.007) after adjustment for covariates and propensity score...
  93. ncbi Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology
    Jean Pierre Bassand
    Members of the Board of the European Society of Cardiology
    Eur Heart J 26:2733-41. 2005
    ....
  94. ncbi Differences in presentation and management of stable angina from East to West in Europe: a comparison between Poland and the UK
    Caroline Ann Daly
    Royal Brompton Hospital, Sydney St London SW3 6NP, UK
    Int J Cardiol 125:311-8. 2008
    ..The aim of this study was to compare the presentation of stable angina to cardiology services in Poland vs. the United Kingdom, the management of the condition in relation to existing European guidelines and clinical outcome...
  95. ncbi Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry
    Jacques Machecourt
    CHU Michallon, Grenoble, France
    J Am Coll Cardiol 50:501-8. 2007
    ..We sought to assess the frequency and causes of stent thrombosis in diabetic and nondiabetic patients after implantation of sirolimus-eluting stents...
  96. ncbi From Archives des Maladies du Coeur et des Vaisseaux to Archives of Cardiovascular Diseases: changing format for improved content
    Nicolas Danchin
    Arch Cardiovasc Dis 101:1. 2008
  97. ncbi [Clinical aspects and risk stratification of acute coronary syndromes without ST-segment elevation]
    Nicolas Danchin
    Département de cardiologie Hôpital européen Georges Pompidou 75908 Paris
    Rev Prat 53:619-23. 2003
    ..These variables can be used to construct risk scores, among which the Timi risk score is the most widely used...
  98. ncbi Residual exercise SPECT ischemia on treatment is a main determinant of outcome in patients with coronary artery disease treated medically at long-term with beta-blockers
    Pierre Y Marie
    Department of Nuclear Medicine and Cardiology, UPRES EA 3447, CHU Nancy Brabois, 54511 Vandoeuvre Cedex, France
    J Nucl Cardiol 10:361-8. 2003
    ..However, it is not known whether beta-blockers have the same beneficial prognostic effect when residual ischemia persists on treatment...
  99. ncbi Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial
    Jeffrey A Gavard
    Division of Cardiology, 15th Floor, St. Louis University School of Medicine, 3635 Vista Avenue at Grand Boulevard, PO Box 15250, St. Louis, MO 63110-0250, USA
    J Thorac Cardiovasc Surg 126:807-13. 2003
    ..Newer cardioprotective agents that reduce the number of patients with marked creatine kinase-myocardial band release are currently being tested in large randomized controlled clinical trials...
  100. ncbi The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial
    Marc Cohen
    Newark Beth Israel Medical Center, Newark, New Jersey 07112, USA
    J Am Coll Cardiol 42:1348-56. 2003
    ....
  101. ncbi Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey
    Vanina Bongard
    Department of Epidemiology, INSERM U558, , 37, , Toulouse, Cedex 7, France
    Int J Cardiol 93:217-23. 2004
    ..CONCLUSIONS: In this study, gender was not an independent determinant of secondary preventive drug prescriptions after acute coronary events. Conversely, we found a gender bias in referral to cardiac rehabilitation programs at discharge...